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location in the RSV had the lowest success rate (87.0%). The Judkins
Left was the most common eventually selected catheter for left cor-
onary artery origin anomalies (45.6%), and for RCA was Amplatz Left
(53.7%). Of the 33 PCI failure cases, 63.6% was chronic total occlusions
in which the catheter backup had more important role, and the ﬁrst
cause of failure was guidewire failure (81.0% for occlusion and 25.0%
for non-occlusion lesion).
CONCLUSIONS COAs are rare, but may cause difﬁculties during PCI
and compromise the success rate of the procedure. The RCA origi-
nating from anomalous location in the RSV is the most difﬁcult type of
anomaly to perform the PCI, and most of the failure cases due to
guidewire failure, especially for those chronic total occlusion lesions.
Awareness of common COAs could be helpful for interventional car-
diologists, to select more appropriate catheters, save more procedure
times, and ultimately achieve better results.
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BACKGROUND Percutaneous coronary interventions within bi-
furcations are high-risk procedures. If they are performed in diabetic
patients, the risk additionally increases. The aim of this study was to
analyze the performance of BiOSS (Balton, Poland) stents in diabetic
patients enrolled into two randomized clinical trials POLBOS I and
POLBOS II.
METHODS The BiOSS stent is a coronary dedicated bifurcation
balloon expandable stent made of 316L stainless steel and coated
with a biodegradable polymer as well as the drug. Presently, there
are two versions of the stent: BiOSS Expert eluting paclitaxel, and
BiOSS LIM eluting sirolimus. The stent consists of two parts with
different diameters connected with two struts (1.5 mm in length).
The aim of randomized POLBOS trials was to compare BiOSS stents
with the regular drug eluting stents (rDES) in patients with stable
CAD or NSTE-ACS (POLBOS I compared BiOSS Expert vs rDES, POL-
BOS II – BiOSS LIM vs rDES). Provisional T-stenting was the default
strategy. An angiographic control was performed at 12 months in all
patients. The primary end-point was MACE at 12 months deﬁned as
cardiac death, myocardial infarction or target lesion revasculariza-
tion (TLR).
RESULTS In both trials 445 patients were enrolled (BiOSS Expert – 120
pts, BiOSS LIM – 102, rDES – 223). The mean age was 66 yrs (28%
women). The rate of diabetes (DM) in BiOSS Expert group was 37.5%
(n ¼ 45), in BiOSS LIM group – 44.1% (n ¼ 45), and in rDES – 28.3% (n ¼
63). In overall population dominant vessel was LAD (BiOSS Expert vs
BiOSS LIM vs DES: 52% 44.1% vs 57%) followed by LM (22% vs 35% vs
24%). According to Medina classiﬁcation true bifurcations were pre-
sent in 64%, 66%, 60%, respectively. In rDES group 30.9% of stents
eluted paclitaxel. The overall TLR rate in BiOSS Expert group was
11.5% (n ¼ 14) [DM: 8.9% (n ¼ 4) vs non-DM: 13.3% (n ¼ 10)], the TLR
rate in BiOSS LIM was 9.8% (n ¼ 10) [DM: 8.9% (n ¼ 4) vs non-DM:
10.5% (n ¼ 6)], whereas in rDES the TLR rate was 8.1% (n ¼ 18) [DM:
14.3% (n ¼ 9), non-DM 5.6% (n ¼ 9)]. In the pooled BiOSS group the
TLR rate was 10.8% (n ¼ 24, p < 0.05) [DM: 8.9% (n ¼ 8, p < 0.05) vs
non-DM: 12.1% (n ¼ 16, p < 0.05)]. After adjusting for age, sex and
LM-bifurcation the OR for TLR in diabetic patients with BiOSS im-
plantation was 0.67 (95% CI 0.57 – 0.76) comparing to rDES. Further
statistical analysis revealed that nominal diameters of restenotic
stents in both groups were signiﬁcantly smaller in DM vs non-DM
subgroups (BiOSS 3.41x2.69 mm vs 3.88x3.16 mm, rDES: 3.03 vs
3.36 mm). Restenotic lesions in all groups were less frequently
encountered in LM bifurcations (BiOSS DM vs nonDM: 12.5% vs 25%,
DES DM vs non-DM 22.2% vs 44.4%).
CONCLUSIONS Collected data demonstrate that both BiOSS stents act
especially well in diabetic population comparing with rDES. This
ﬁnding might suggest the stent design is more important in bifurca-
tion lesions treatment than the drug.
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BACKGROUND The use of trans-radial approach (TRA) to treat coro-
nary complex lesions like chronic total occlusions (CTO), is increasing
thanks to low rate of access site complications, good percutaneous
coronary interventions (PCI) results and advances in material tech-
nology. The aim of the study was to retrospectively review the pro-
cedural and clinical results of PCI for CTO lesions performed by radial
approach by radialists working in centers with an high number of PCI
performed by radial approach.
METHODS we collected clinical and procedural data of CTO PCI per-
formed using radial approach in the period from January 2008 to April
2014. Primary end-points were PCI success (stent implantation with
residual stenosis< 20% and TIMI 3) and patient success (PCI success in
a ﬁrst or second attempt). Access site complications, cardiac intra-
procedural complications and in-hospital major cardiac adverse
events (MACEs: cardiac death, myocardial infarction (MI), re-PCI or
CABG) were also assessed.
RESULTS Seven centers afferent to the Italian Radial Club (an asso-
ciation of italian centers dedicated to the dissemination of the radial
approach between interventionalists) participated to the study. A total
of 359 TRA PCI of CTO lesions in 347 patients were performed. The
selection of the CTO lesions to be treated by TRA was done according
to the operator choice. The complexity of CTO lesions treated was:
tapered lesions in 43,7%, stump lesions in 40,4%, microchannels in
36%, occlusion site not visible and/or caput medusae in 14% of cases.
CTO length was > 20 mm in 87.5% of cases. Majority of PCI (98,9%)
were performed by antegrade approach with a double radial approach
for collateral injections in 20% of cases. Only 4 cases were performed
using a biradial retrograde approach. A 6 F guiding catheter was used
in the majority of cases (95.8%). In only 22 patients (6%) was needed
to switch from radial to femoral approach. The PCI success rate was
69% and patient success rate was 71%. In successful cases, stents were
implanted in the majority (97,2%) with a mean number of stents per
patients of 1.7  0.9. The rate of drug eluting stents use was 91%.
There were only 1 access site complication (pseudoaneurism of radial
artery solved by compression) and only 4 cardiac intraprocedural
complications (pericardial effusions). The rate of in-hospital MACEs
was 1.7% with 1 cardiac death, 1 MI, 3 re-PCI and 3 patients undergoing
CABG.
CONCLUSIONS According to our multicentric retrospective registry
TRA to treat CTO lesions, deemed feasible with this approach by an
expert operator, is safe and associated with a good procedural and
patient success.
CATEGORIES CORONARY: Complex and Higher Risk Procedures for
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BACKGROUND The importance of complete revascularization re-
mains unclear and contradictory. This study compares the long term
B160 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5prognosis of complete revascularization (CR) versus incomplete
revascularization (IR) on patients with multivessel coronary artery
disease (CAD) who underwent percutaneous coronary intervention
(PCI) or coronary artery bypass graft (CABG).
METHODS From May 2003 to December 2013, a total of 9,582 patients
were analyzed who underwent PCI or CABG for multivessel disease.
Major adverse cardiac event(MACE) including all-cause death,
myocardial infarction and repeat revascularization was compared
between CR and IR group.
RESULTS CR was achieved in 4,423 patients (46.2%); IR was more
common after PCI than CABG (62.1% vs. 39.6%, p<0.001) and IR group
presented with more myocardial infarction than CR group (30.4%
vs.24.6%, p<0.001). During a 10-year follow-up, MACE occurred more
in IR than CR group(44.4% vs. 36.9%, P<0.001). Relative to IR, CR was
associated with lower long-term mortality (adjusted hazard ratio [HR]:
0.876, 95% conﬁdence interval [CI]:0.782 to 0.982, p¼0.023),
myocardial infarction (HR: 0.680, 95% CI: 0.524 to 0.882, p¼0.004),
and repeat revascularization (HR: 0.777, 95% CI: 0.682 to 0.887,
p<0.001). And the survival free from MACE was most beneﬁted in
completely revascularized CABG patients (HR: 0.575, 95% CI: 0.509 to
0.648, p¼0.005).
Table 1. Characteristics of the patients who underwent complete and incomplete revascularizationComplete
(n[4423)Incomplete
(n[5159) p-valueAge (years) 62.76  9.46 63.46  9.79 <0.001
Male 3194 (72.2%) 3815 (73.9%) 0.056Hypertension 2726 (61.6%) 3248 (63.0%) 0.182Diabetes 1697 (38.4%) 1970 (38.2%) 0.867Chronic Kidney Disease (GFR<60) 739 (16.7%) 1009 (19.6%) <0.001Congestive Heart Failure (EF35%) 204 (4.6%) 212 (4.1%) 0.228
Presentation of myocardial infarction 1090 (24.6%) 1568 (30.4%) <0.001Three-vessel disease % 2188 (49.5%) 2940 (57.0%) <0.001Chronic total occlusion % 352 (8%) 286 (5.5%) <0.001Treatment strategy (PCI) 2292 (51.8%) 3760 (72.9%) <0.001Drug eluting stent % 2001 (45.2%) 3217 (62.6%) 0.056CONCLUSIONS In a 10-year follow-up, the achievement of CR in
multivessel CAD was associated with reduced MACE rate, irrespective
of revascularization strategy in the real world.
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BACKGROUND Percutaneous management of ULM disease has gained
guideline acceptance for those with low-to moderate SYNTAX scores.
There are few data to guide best management of restenosis in this
setting. We sought to evaluate the management and outcomes of
restenosis after unprotected left main (ULM) stenting.
METHODS From a total sample of all patients presenting for angiog-
raphy between January 2009 and December 2014 with ULM lesion >
50% (n¼ 1,363), we identiﬁed those with angiographically signiﬁcant
ULM in lesion restenosis (n¼42). The primary end-point was long-
term rate of major adverse cardiac events (MACE) – that is death,
myocardial infarction (MI) or clinically driven target lesion revascu-
larization (TLR).
RESULTS Signiﬁcant ULM lesion restenosis was identiﬁed in 43
patients (3%). The clinical indication for angiography was stable
angina in 33 (78%), non ST-elevation MI in 8 (18%), ST-elevation MI
in 1 (2%) and cardiac arrest in 1 (2%). The initial stenting strategy
was a simple one-stent approach in 24 (56%) and a complex 2-stent
technique in 19 (44%). Details of the initial stent utilized were
available in 37 – drug eluting stent 29 (78 %), bare metal stent
(BMS) 5 (14%) and bioresorbable vascular scaffolds 3 (8%). Reste-
nosis was treated percutaneously in 26 patients (60%) - additional
DES in 22 (84%); balloon angioplasty in 3 (12%); thromboaspiration
in 1 (4%). The remaining 40% were managed surgically. Table 1
shows clinical details by treatment strategy. For those undergoing
repeat PCI a simple 1-stent strategy was employed in 19 (86%).
In-hospital MACE rates was 7% with individual components of
death 4.7% (2) and MI 2.3% (1). After 30þ19 months follow-up
cumulative MACE rate was 23.3% comprising of death in 5 (12%),
MI in 2 (4.7%) and re-TLR in 1 (2.3%). There was no reported
MACE in the surgically managed group.PCI (n[26) CABG (n[17)Age (years) 7413 6313
Male (%) 69 71eGFR (ml/min) 5226 7222
Diabetes (%) 38 47Clinical PresentationStable (n) 18 11NSTEMI (n) 5 6STEMI (n) 2 0Cardiac arrest (n) 1 0Initial strategy1-stent (%) 62 532-stent (%) 38 47CONCLUSIONS Restenosis after ULM stenting presents with a stable
clinical course and can be percutaneously managed with a simple one-
stent strategy in the majority of cases with low repeat TLR rates. The
higher MACE rates for those managed percutaneously may be
explained by operator bias to treat older, more unstable patients with
repeat PCI.
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